Adverum Biotechnologies, Inc. - Common Stock, par value $0.0001 per share (ADVM)

CUSIP: 00773U108

Q3 2017 13F Holders as of 30 Sep 2017

Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
22,163,711
Total 13F shares
13,572,084
Share change
+616,938
Total reported value
$49,476,022
Price per share
$3.65
Number of holders
56
Value change
+$3,295,007
Number of buys
24
Number of sells
25

Quarterly Holders Quick Answers

What is CUSIP 00773U108?
CUSIP 00773U108 identifies ADVM - Adverum Biotechnologies, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of ADVM - Adverum Biotechnologies, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
ADAGE CAPITAL PARTNERS GP, L.L.C.
13F
Company
9%
2,000,000
$5,000,000 30 Jun 2017
13F
FMR LLC
13F
Company
8.2%
1,808,089
$4,520,000 30 Jun 2017
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
6.4%
1,423,940
$3,560,000 30 Jun 2017
13F
EcoR1 Capital, LLC
13F
Company
3.9%
874,447
$2,186,000 30 Jun 2017
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
2.7%
590,164
$1,475,000 30 Jun 2017
13F
Numeric Investors LLC
13F
Company
2.5%
559,150
$1,398,000 30 Jun 2017
13F
VANGUARD GROUP INC
13F
Company
2.5%
547,748
$1,370,000 30 Jun 2017
13F
PRIMECAP MANAGEMENT CO/CA/
13F
Company
2.2%
490,700
$1,227,000 30 Jun 2017
13F
683 Capital Management, LLC
13F
Company
1.9%
425,000
$1,063,000 30 Jun 2017
13F
BlackRock Finance, Inc.
13F
Company
1.5%
337,966
$845,000 30 Jun 2017
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
1.4%
304,741
$762,000 30 Jun 2017
13F
VHCP Management II, LLC
13F
Company
1.3%
280,000
$700,000 30 Jun 2017
13F
OXFORD ASSET MANAGEMENT LLP
13F
Company
1%
229,669
$574,000 30 Jun 2017
13F
Connor, Clark & Lunn Investment Management Ltd.
13F
Company
1%
229,350
$573,000 30 Jun 2017
13F
AWM Investment Company, Inc.
13F
Company
0.9%
200,000
$500,000 30 Jun 2017
13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC
13F
Company
0.83%
183,900
$460,000 30 Jun 2017
13F
JW Asset Management, LLC
13F
Company
0.81%
178,654
$447,000 30 Jun 2017
13F
Sessa Capital IM, L.P.
13F
Company
0.77%
171,487
$429,000 30 Jun 2017
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.76%
168,032
$420,000 30 Jun 2017
13F
Paloma Partners Management Co
13F
Company
0.74%
165,100
$413,000 30 Jun 2017
13F
Rhenman & Partners Asset Management AB
13F
Company
0.69%
154,006
$385,000 30 Jun 2017
13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM
13F
Company
0.66%
145,600
$364,000 30 Jun 2017
13F
ELEMENT CAPITAL MANAGEMENT LLC
13F
Company
0.56%
124,713
$312,000 30 Jun 2017
13F
BARCLAYS PLC
13F
Company
0.51%
113,933
$285,000 30 Jun 2017
13F
SCHRODER INVESTMENT MANAGEMENT GROUP
13F
Company
0.5%
110,939
$278,000 30 Jun 2017
13F
SABBY MANAGEMENT, LLC
13F
Company
0.5%
110,000
$275,000 30 Jun 2017
13F
PANAGORA ASSET MANAGEMENT INC
13F
Company
0.49%
108,503
$271,000 30 Jun 2017
13F
DEUTSCHE BANK AG\
13F
Company
0.45%
98,839
$246,000 30 Jun 2017
13F
LMR Partners LLP
13F
Company
0.44%
97,780
$244,000 30 Jun 2017
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.43%
95,252
$238,000 30 Jun 2017
13F
JACOBS LEVY EQUITY MANAGEMENT, INC
13F
Company
0.37%
81,991
$205,000 30 Jun 2017
13F
JPMORGAN CHASE & CO
13F
Company
0.33%
72,755
$182,000 30 Jun 2017
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
0.29%
64,706
$162,000 30 Jun 2017
13F
TWO SIGMA INVESTMENTS, LP
13F
Company
0.28%
62,325
$156,000 30 Jun 2017
13F
Virtu KCG Holdings LLC
13F
Company
0.26%
57,631
$144,000 30 Jun 2017
13F
GILDER GAGNON HOWE & CO LLC
13F
Company
0.2%
44,556
$111,000 30 Jun 2017
13F
Bank of New York Mellon Corp
13F
Company
0.17%
38,711
$97,000 30 Jun 2017
13F
A.R.T. Advisors, LLC
13F
Company
0.15%
33,659
$84,000 30 Jun 2017
13F
HIGHBRIDGE CAPITAL MANAGEMENT LLC
13F
Company
0.15%
33,170
$83,000 30 Jun 2017
13F
NORTHERN TRUST CORP
13F
Company
0.15%
32,231
$80,000 30 Jun 2017
13F
Marquette Asset Management, LLC
13F
Company
0.12%
25,998
$65,000 30 Jun 2017
13F
Redmile Group, LLC
13F
Company
0.1%
22,236
$56,000 30 Jun 2017
13F
J.P. Morgan Private Wealth Advisors LLC
13F
Company
0.09%
20,000
$50,000 30 Jun 2017
13F
STEVENS CAPITAL MANAGEMENT LP
13F
Company
0.08%
17,333
$43,000 30 Jun 2017
13F
PARAMETRIC PORTFOLIO ASSOCIATES LLC
13F
Company
0.07%
15,710
$39,000 30 Jun 2017
13F
Wildcat Capital Management, LLC
13F
Company
0.07%
15,000
$38,000 30 Jun 2017
13F
Squarepoint Ops LLC
13F
Company
0.05%
10,303
$26,000 30 Jun 2017
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.03%
7,540
$19,000 30 Jun 2017
13F
GROUP ONE TRADING LLC
13F
Company
0.03%
6,895
$17,000 30 Jun 2017
13F
IFP Advisors, Inc
13F
Company
0.03%
6,000
$15,000 30 Jun 2017
13F

Institutional Holders of Adverum Biotechnologies, Inc. - Common Stock, par value $0.0001 per share (ADVM) as of Q3 2017

As of 30 Sep 2017, Adverum Biotechnologies, Inc. - Common Stock, par value $0.0001 per share (ADVM) was held by 56 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 13,572,084 shares. The largest 10 holders included ADAGE CAPITAL PARTNERS GP, L.L.C., RENAISSANCE TECHNOLOGIES LLC, FMR LLC, VANGUARD GROUP INC, EcoR1 Capital, LLC, Sessa Capital IM, L.P., 683 Capital Management, LLC, DIMENSIONAL FUND ADVISORS LP, PRIMECAP MANAGEMENT CO/CA/, and MANGROVE PARTNERS. This page lists 56 institutional shareholders reporting positions in this security for the Q3 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q3 2017 vs Q2 2017 Across Filers

Q2 2017 holders
60
Q3 2017 holders
56
Holder diff
-4
Investor Q2 2017 Shares Q3 2017 Shares Share Diff Share Chg % Q2 2017 Value $ Q3 2017 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.